Companies

Curidium Medica

Overview

Curidium is developing diagnostic tools that can be used to assess how individual patients will respond to treatments. Homomatrix is a technology that can identify specific patient subgroups. This can help doctors to prescribe the most appropriate treatment to a patient, which is known as personalised medicine. The main focus is central nervous system (CNS) ailments but the same diagnostics platform could be used as a basis for other medical areas. Curidium was established in 2001 and it reversed into Cielo Holdings in July 2006. On 8 March 2008, 30 shares were consoldiated in one new share.

Sector: Health

• Curidium Medica Posted: 02/08/2007

News blog

• Curidium Medica/Avacta Group Posted: 09/02/2009
• Curidium Medica/Avacta Group Posted: 18/01/2009
• Curidium Medica Posted: 11/01/2009
• Curidium Medica Posted: 12/05/2008
• Curidium Medica Posted: 05/12/2007

Browse by sector

All companies

• Aim advisers
• Aim Awards
• Aim investor relations
• Cleantech
• Construction
• Consumer
• Electricals
• Financial
• Food
• Health
• Industrial
• Leisure
• Media
• Mobile
• Property
• QUOTED MICRO
• Resources
• Retail
• Security
• Services
• Technology
• Telecoms
• Training
• Transport

• 2.4mNumber of messages posted on SocialGo networks
  
• $38mCost savings generated by ideas from WalMart staff over a two month period